Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Radnostix, Inc. (formerly International Isotopes Inc.) is a diversified radioisotope, radiopharmaceutical, and medical device company based in Idaho Falls, Idaho. Founded in 1995, the company manufactures and distributes a wide range of nuclear medicine products, including generic sodium iodide I-131 for hyperthyroidism and thyroid cancer, calibration and reference standards under its RadQual brand, and Cobalt-60 sealed sources. Radnostix also develops and distributes medical devices and equipment, such as the LARA System for monitoring radiopharmaceutical administration, the EasyFill Automated Capsule System, and RadVent respiratory products. The company operates a vertically integrated manufacturing platform with FDA-registered and NRC-licensed facilities, serving hospitals, radiopharmacies, and research institutions globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Radnostix.